Boston Scientific Corporation (BSX)

Boston Scientific Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Cash & Equivalents	1,453	1,965	1,275	534	725	414	2,502	2,913	2,329	865	952	426	570	928	338	276	325	1,925	1,947	2,675
Cash & Short-Term Investments	1,453	1,965	1,275	534	725	414	2,502	2,913	2,329	865	952	426	570	928	338	276	325	1,925	1,947	2,675
Cash Growth	100.41%	374.64%	-49.04%	-81.67%	-68.87%	-52.14%	162.81%	583.80%	308.60%	-6.79%	181.66%	54.35%	75.39%	-51.79%	-82.64%	-89.68%	-83.88%	11.02%	-3.71%	55.16%
Accounts Receivable	3,027	2,926	2,828	2,815	2,693	2,558	2,501	2,400	2,304	2,228	2,101	2,134	2,076	1,970	1,871	1,917	1,866	1,778	1,669	1,675
Inventory	3,117	2,943	2,921	2,861	2,867	2,810	2,753	2,608	2,561	2,484	2,404	2,250	2,050	1,867	1,788	1,752	1,736	1,610	1,603	1,430
Other Current Assets	1,087	959	1,011	911	1,050	1,138	1,006	1,071	990	936	1,048	1,076	1,007	995	1,146	1,138	1,138	1,004	1,009	979
Total Current Assets	8,684	8,794	8,035	7,121	7,335	6,920	8,761	8,991	8,185	6,514	6,504	5,886	5,704	5,760	5,144	5,083	5,065	6,317	6,229	6,758
Net Property, Plant & Equipment	4,063	4,036	3,795	3,461	3,389	3,294	3,072	2,951	2,897	2,859	2,635	2,534	2,478	2,446	2,273	2,246	2,265	2,252	2,109	2,082
Other Intangible Assets	7,060	7,019	7,162	7,260	6,566	6,684	5,754	5,417	5,839	6,003	5,849	6,063	6,060	5,902	6,058	6,349	6,581	6,121	6,227	5,788
Goodwill	18,536	18,282	18,214	18,076	17,340	17,089	15,033	14,397	14,361	14,387	13,608	13,659	13,269	12,920	12,852	12,883	12,949	11,988	11,820	10,874
Other Long-Term Assets	6,007	5,541	5,501	5,642	5,510	5,409	5,458	5,352	5,388	5,372	5,445	5,460	5,382	5,442	5,620	5,628	5,477	5,552	5,493	5,665
Total Assets	44,351	43,673	42,707	41,559	40,140	39,395	38,078	37,108	36,669	35,136	34,043	33,601	32,892	32,469	31,947	32,189	32,337	32,229	31,877	31,168
Accounts Payable	1,141	1,144	1,002	962	1,004	960	907	906	921	942	929	899	868	862	803	732	696	794	674	689
Accrued Expenses	2,514	3,201	2,981	2,797	2,354	2,773	2,460	2,320	2,083	2,646	2,255	2,164	1,918	2,160	1,974	2,197	2,306	2,436	2,418	2,442
Short-Term Debt	41	299	483	480	777	1,778	1,652	1,580	1,085	531	513	559	510	20	20	170	238	261	261	262
Other Current Liabilities	875	795	862	952	923	887	891	770	827	814	882	940	787	761	752	784	1,034	783	669	680
Total Current Liabilities	4,571	5,439	5,328	5,190	5,058	6,399	5,910	5,576	4,916	4,933	4,579	4,562	4,083	3,803	3,549	3,883	4,275	4,274	4,022	4,073
Long-Term Debt	10,988	11,137	11,117	11,107	10,532	8,968	9,233	8,991	9,534	8,571	8,386	8,494	8,495	8,915	8,564	8,802	9,067	8,804	8,824	8,847
Other Long-Term Liabilities	2,688	2,625	2,632	2,609	2,104	2,025	1,979	1,932	2,051	2,101	1,949	2,061	2,205	2,179	2,194	2,253	2,261	2,530	2,570	2,305
Total Long-Term Liabilities	13,676	13,762	13,749	13,716	12,636	10,993	11,212	10,923	11,585	10,672	10,335	10,555	10,700	11,094	10,758	11,055	11,328	11,334	11,394	11,152
Total Liabilities	18,247	19,201	19,077	18,906	17,694	17,392	17,122	16,499	16,501	15,605	14,914	15,117	14,783	14,897	14,307	14,938	15,603	15,608	15,416	15,225
Common Stock	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17
Treasury Stock	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251
Additional Paid-in Capital	21,584	21,505	21,419	21,230	21,127	21,056	20,963	20,803	20,713	20,647	20,573	20,441	20,356	20,289	20,219	20,103	20,043	19,986	19,930	19,817
Accumulated Other Comprehensive Income	-398	-610	-689	-722	-28	275	-128	164	132	49	231	208	178	269	532	433	222	263	238	237
Retained Earnings	6,912	5,571	4,899	4,144	3,347	2,673	2,107	1,639	1,314	819	315	-189	-450	-750	-876	-1,050	-1,296	-1,392	-1,473	-1,878
Total Common Shareholders' Equity	25,864	24,233	23,394	22,418	22,212	21,770	20,708	20,371	19,926	19,282	18,886	18,226	17,850	17,573	17,640	17,251	16,735	16,622	16,462	15,942
Minority Interest	240	239	236	235	233	233	248	238	242	248	243	259	259	-	-	-	-	-	-	-
Shareholders' Equity	26,104	24,472	23,630	22,653	22,446	22,003	20,956	20,609	20,168	19,530	19,129	18,485	18,109	17,573	17,640	17,251	16,735	16,622	16,462	15,942
Total Liabilities & Equity	44,351	43,673	42,707	41,559	40,140	39,395	38,078	37,108	36,669	35,136	34,043	33,601	32,892	32,469	31,947	32,189	32,337	32,229	31,877	31,168
Total Debt	11,029	11,436	11,600	11,587	11,309	10,746	10,885	10,571	10,619	9,102	8,899	9,053	9,005	8,935	8,584	8,972	9,305	9,065	9,085	9,109
Net Cash (Debt)	-9,576	-9,471	-10,325	-11,053	-10,584	-10,332	-8,383	-7,658	-8,290	-8,237	-7,947	-8,627	-8,435	-8,007	-8,246	-8,696	-8,980	-7,140	-7,138	-6,434
Net Cash Per Share	-6.41	-6.33	-6.90	-7.40	-7.09	-6.93	-5.64	-5.16	-5.59	-5.58	-5.39	-5.92	-5.83	-5.55	-5.73	-6.05	-6.24	-4.97	-4.97	-4.49
Book Value	25,864	24,233	23,394	22,418	22,212	21,770	20,708	20,371	19,926	19,282	18,886	18,226	17,850	17,573	17,640	17,251	16,735	16,622	16,462	15,942
Book Value Per Share	17.30	16.20	15.64	15.01	14.88	14.61	13.92	13.73	13.45	13.06	12.80	12.52	12.34	12.18	12.25	12.00	11.63	11.57	11.47	11.13
Tangible Book Value	268	-1,068	-1,982	-2,918	-1,694	-2,003	-79	557	-274	-1,108	-571	-1,496	-1,479	-1,249	-1,270	-1,981	-2,795	-1,487	-1,585	-720
Tangible Book Value Per Share	0.18	-0.71	-1.33	-1.95	-1.13	-1.34	-0.05	0.38	-0.18	-0.75	-0.39	-1.03	-1.02	-0.87	-0.88	-1.38	-1.94	-1.04	-1.10	-0.50

Updated May 1, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q